Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Core Insights - Cognizant has expanded its partnership with Gilead Sciences to enhance customer service, employee engagement, and business value through AI-driven solutions [1][3] - The collaboration aims to improve cost leadership and productivity for Gilead while leveraging machine learning and generative AI [1][4] - Cognizant's Neuro AI generative AI platform will be utilized to accelerate value creation and improve operational efficiencies for Gilead [3][4] Company Overview - Cognizant has supported Gilead's global IT infrastructure and digital transformation initiatives over the past decade [2] - Gilead Sciences is a biopharmaceutical company focused on developing innovative medicines for life-threatening diseases, operating in over 35 countries [6] Partnership Goals - The expanded agreement seeks to provide significant cost savings that can be reinvested into Gilead's core life sciences business [3] - Cognizant aims to transform the user experience of IT services with custom-built generative AI solutions [3][4] - The partnership is expected to enhance operational efficiencies through leading-edge automation and managed services frameworks [4]